John Cox Email Address
@bioverativ.com
Executive Chairman
Bioverativ is a global biotechnology company dedicated to transforming the lives of people living with hemophilia and other blood disorders.
"We intend to build the leading hematology company and always put the patient first." In 2016, Biogen Inc. announced its intention to spin off its hemophilia business as an independent, publicly traded company. The new company formed on February 1, 2017, is named Bioverativ. It will focus on the discovery and development of therapies for the treatment of hemophilia and other blood disorders, with existing marketed products for the treatment of hemophilia A and B. I am honored to be the new company’s Chief Executive Officer. In 2014, Biogen brought to market the first major treatment advances in nearly two decades for people living with hemophilia. I’m extremely excited to build on this legacy, lead a management team that’s passionate about hemophilia and further advance that innovative progress. With a team that is solely dedicated to hemophilia, we will have the potential to transform the way hemophilia patients are treated.
Other people working at Bioverativ:
How does this work?
Anymail finder is trusted by tens of thousands of companies to provide accurate contact information to their Sales and Business Development teams.
If you’re looking to find the email of John Cox at Bioverativ then you’ve come to the right place.
Wondering if it's john@bioverativ.com, john.cox@bioverativ.com, cox@bioverativ.com, or jcox@bioverativ.com? We have the answers for you.